Ewopharma UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 183,534 |
| 48,554 |
| 14,824 |
| 12,600 |
| 3,333 |
| 2.91 |
| 6.87 |
| 18,073 |
| 45,835 |
| 22,335 |
| 50,818 |
| 0.14 |
| 2.54 |
| - |
| - |
| 8.07 |
| 14,818 |
| 2024 |
|---|
| 224,864 |
| 62,289 |
| 8,649 |
| 6,259 |
| 1,734 |
| 3.82 |
| 2.78 |
| 24,331 |
| 44,609 |
| 18,835 |
| 64,118 |
| 0.17 |
| 1.83 |
| - |
| - |
| 3.82 |
| 8,582 |
| 2025 |
|---|
| 342,146 |
| 93,739 |
| 14,674 |
| 11,454 |
| 3,138 |
| 4.25 |
| 3.35 |
| 35,785 |
| 49,029 |
| 38,325 |
| 60,084 |
| -0.01 |
| 1.37 |
| - |
| - |
| 4.25 |
| 14,553 |
| 2025 |
|---|
| 342,146 |
| 93,739 |
| 14,674 |
| 11,454 |
| 3,138 |
| 4.25 |
| 3.35 |
| 35,785 |
| 49,029 |
| 38,325 |
| 60,084 |
| -0.01 |
| 1.37 |
| - |
| - |
| 4.25 |
| 14,553 |
Turnover (€)
2025
Turnover (€)
342,146 €52 % *
Sales per employee (€)
93,739 €50 % *
Profit before tax (€)
14,674 €70 % *
Net Profit (€)
11,454 €83 % *
Profit per employee (€)
3,138 €81 % *
Total profitability (%)
4.25 %11.26 % *
Net profitability (%)
3.35 %20.50 % *
Equity (€)
35,785 €47 % *
Amounts Payable And Liabilities (€)
49,029 €10 % *
Non-current Assets (€)
38,325 €103 % *
CurrentAssets (€)
60,084 €-6 % *
Working capital requirement
-0.01 -105.88 % *
Debt-to-equity ratio
1.37 -25.14 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
4.25 %11.26 % *
EBIT (€)
14,553 €70 % *
